• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

New Diabetes Guidelines Have It Both Ways

Article

A new guideline calls for a tailored approach to treating type 2 diabetes while maintaining the use of an algorithm-based model, researchers said.

The new recommendations from the American Association of Clinical Endocrinologists (AACE) offer an algorithm that involves every FDA approved class of medications for managing hyperglycemia, while still suggesting consideration of individual patient characteristics such as age and comorbidities, Alan Garber, MD, PhD, of Baylor College of Medicine in Houston, and colleagues reported in Endocrine Practice.

"The majority of patients aren't reaching goal," Garber told MedPage Today. "We think a more assertive recommendation of treatments will help physicians get patients to goal and avoid the pitfalls of certain medications."

Read the full story here: http://bit.ly/ZIBaoW

Source: MedPageToday.com

Related Videos
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.